Lola Corzo

A 24‐week, double‐blind, placebo‐controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

X.A. Alvarez, R Cacabelos, M. Laredo et al. · European Journal of Neurology · 2006 · 98 citations

Medicine, Neurology, Pharmacology +15

Sirtuins in Alzheimer’s Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGenetics

Ramón Cacabelos, Juan C. Carril, Natalia Cacabelos et al. · International Journal of Molecular Sciences · 2019 · 84 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics.

R Cacabelos, Valter Lombardi, L. Fernández‐Novoa et al. · PubMed · 2000 · 70 citations

Medicine, Neuroscience, Pharmacology +17

Genomics of Dementia:<i>APOE</i>- and<i>CYP2D6</i>-Related Pharmacogenetics

Ramón Cacabelos, Rocío Martínez, L. Fernández‐Novoa et al. · International Journal of Alzheimer s Disease · 2012 · 56 citations · Full text

Medicine, Genetics, Pharmacology +17

Decreased levels of serum nitric oxide in different forms of dementia

Lola Corzo, R. Zas, Susana Rodríguez et al. · Neuroscience Letters · 2007 · 52 citations

Medicine, Geriatric Medicine, Neurology +10